A preliminary controlled evaluation of the antihypertensive effect of indapamide
- 1 January 1977
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 4 (8) , 596-601
- https://doi.org/10.1185/03007997709115276
Abstract
A controlled, single-blind trial was carried out in 10 hypertensive patients to compare the effectiveness of a single daily dose (2.5 mg to 5 mg) of indapamide with that of placebo. Blood pressure was measured with a bias-free sphygmomanometer. Indapamide produced a significant reduction in mean systolic and diastolic pressures in both supine and erect positions. It was generally well tolerated: few side-effects were reported and no significant changes were noted in laboratory tests. It is concluded that further long-term studies of indapamide are indicated in larger numbers of patients.Keywords
This publication has 3 references indexed in Scilit:
- A comparative study of the activity of a new agent, indapamide, in essential arterial hypertensionCurrent Medical Research and Opinion, 1975
- Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulnessPublished by Oxford University Press (OUP) ,1974
- Treatment of hypertension with a new beta-blocking agent, pindolol (Visken®)European Journal of Clinical Pharmacology, 1973